Skip to main content

Table 1 Clinical characteristics

From: Epidemiologic characteristics and double-buffered strategy for patients in orthopedic surgery during the novel coronavirus outbreak: Wuhan’s experience

Groups

The epidemic group

The control group

P value

Number

N = 82

N = 342

 

Age, years; mean (SD)

54.6 (20.2)

48.6 (22.5)

P = 0.028

Gender, n (%)

  

P = 0.121

 Male

54 (65.9%)

193 (56.4%)

 

 Female

28 (34.1%)

149 (43.6%)

 

Injury priority, n (%)

  

P < 0.001

 Priority A

6 (7.3%)

45 (13.2%)

 

 Priority B

8 (9.8%)

37 (10.8%)

 

 Priority C

68 (82.9%)

131 (38.3%)

 

 Priority D

0

89 (26.0%)

 

 Priority E

0

40 (11.7%)

 

Type of diseases, n (%)

  

P < 0.001

 Traumatic fractures

57 (69.5%)

121 (35.4%)

 

 Non-traumatic diseases

25 (30.5%)

221 (64.6%)

 

  Bone tumors

5 (6.1%)

27 (7.9%)

 

  Tuberculosis

4 (4.9%)

12 (3.5%)

 

  Degenerative spinal disease

12 (14.6%)

65 (19.0%)

 

  Arthropathy

4 (4.9%)

20 (5.8%)

 

  Others

0

97 (28.4%)

 

Injury causes, n (%)

  

P < 0.001

 Low-energy injuries

49 (86.0%)

45 (37.2%)

 

 High-energy injuries

8 (14.0%)

76 (62.8%)

 

Fracture location, n (%)

  

P = 0.003

 Elderly osteoporotic fractures (≥ 55 years)

28 (49.1%)

22 (18.2%)

 

 Limb fractures (≤ 55 years)

15 (26.3%)

63 (52.1%)

 

 Spinal cord injuries

7 (12.3%)

16 (13.2%)

 

 Multiple fractures

7 (12.3%)

20 (16.5%)

 

Type of fracture, n (%)

  

P < 0.001

 Closed fracture

53 (93.0%)

73 (60.3%)

 

 Open fracture

4 (7.0%)

48 (39.7%)

 

Preoperative waiting time, mean (SD)

7.0 (2.6)

4.5 (2.1)

P < 0.001

Perioperative complications, n (%)

13 (12.2%)

12 (3.5%)

P < 0.001

 Cardiovascular complications

2 (15.4%)

4 (33.3%)

 

 Venous thromboembolism

8 (61.5%)

3 (25.0%)

 

 Pneumonia

3 (23.1%)

5 (41.7%)

 

Screening effect, n (%)

   

 Excluded COVID-19

80 (97.6%)

  

 Confirmed COVID-19

2 (2.4%)

  

Nosocomial infection, n (%)

0